Try GOLD - Free
Upskilling and flexibility are key to staying relevant as hiring grows
BioSpectrum Asia
|BioSpectrum Asia June 2025
With ongoing uncertainty, geopolitical tensions, and recession risks, the life sciences job market remains volatile. The year 2024 saw continued layoffs, cautious investor sentiment, and growing competition for fewer job openings. As biopharma companies restructure, hiring patterns are changing, especially at mid and senior levels. What are the current trends, and which sectors are hiring the most? Let's find out.
The biopharma job market has been tough, with widespread downsizing and frequent layoffs across big pharma. But the worst may be over. Hiring activity is picking up, especially in the Asia-Pacific (APAC) region. A quick search on our sister website, BioSpectrum jobs for April and May 2025 shows strong, diverse recruitment across all levels from internships to senior leadership in key hubs like Singapore, Tokyo, Bengaluru, and Shanghai. Demand is high for clinical research, regulatory affairs, medical science liaison, and digital marketing roles, while leadership hiring focuses on strategy, sales, and commercial functions.
“The pharmaceutical sector's job landscape has showcased an improving trend in recent months. For instance, job postings were up by around 8 per cent in April 2025 compared to the previous month. Similarly, March 2025 also saw job postings register a month-on-month growth of more than 25 per cent,” said Sherla Sriprada, Senior Business Fundamentals Analyst at GlobalData.
This sustained uptick in hiring reflects how companies are responding to evolving workforce dynamics and talent demands.
“The biopharma job market is experiencing several key trends. High executive turnover, as observed in 2024, continues to influence recruitment needs. Companies are leveraging headquarters and regional resources to supplement local talent with global expertise. They are also focusing on candidates who can learn and grow in dynamic environments, due to cautious attitudes toward job changes and the emergence of younger generations,” said Terrence Chen, Manager, Robert Walters China.
Sherla mentions that there have been notable job postings for roles related to clinical trials, regulatory compliance, immuno-oncology, cell & gene therapy, and digital therapeutics. Meanwhile, there is also demand for senior positions and the skills sought for these roles typically include:
- Leadership experience
This story is from the BioSpectrum Asia June 2025 edition of BioSpectrum Asia.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 9,500+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM BioSpectrum Asia

BioSpectrum Asia
Collaborative R&D: Partnerships shaping the future of biopharma
Biotechs and pharma companies face rising costs of drug development, depleting R&D pipelines and diminishing returns on investment. By joining forces and exploring collaborative R&D partnerships it is possible to overcome these challenges. In addition to sharing risks, they share the potential rewards when their assets move further into clinical development or come to the market.
2 mins
BioSpectrum Asia Sep 2025

BioSpectrum Asia
Quantum Computing: Future of diagnostics is being coded today
A silent revolution is being built at the intersection of biology and quantum physics. After decades of pushing the boundaries of diagnostics with advanced imaging and AI, we are now approaching a hard computational wall. For complex conditions like Alzheimer's, Parkinson's, and many cancers, the interacting variables of genomics, proteomics, and real-world patient data are simply too vast for classical computers to master. This limitation caps the ability to move from merely spotting correlations to uncovering true causation. Unlike traditional AI, quantum computing can simulate underlying physical systems to derive precise solutions. The transition from correlational analysis to causal simulation will enable a more valuable and advanced frontier in diagnostics.
4 mins
BioSpectrum Asia Sep 2025
BioSpectrum Asia
First Pacific woman to serve as public health director in NZ
The Ministry of Health in New Zealand (NZ) has appointed Dr Corina Grey as the new Director of Public Health this year, a landmark appointment for Pacific leadership.
1 min
BioSpectrum Asia Sep 2025
BioSpectrum Asia
Bio-Rad appoints Rajat Mehta as Executive Vice President of Global Commercial Operations
Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, has announced the appointment of Rajat Mehta as its new Executive Vice President, Global Commercial Operations, effective August 4, 2025.
1 min
BioSpectrum Asia Sep 2025

BioSpectrum Asia
Hugel launches botulinum toxin Letybo in Malaysia
South Korea-based Hugel Inc., a leading global medical aesthetics company, has officially launched its botulinum toxin product Letybo in Malaysia - an emerging market for medical aesthetics in Southeast Asia.
1 min
BioSpectrum Asia Sep 2025

BioSpectrum Asia
Australia designs smart wound monitor to improve chronic infection care
Researchers from Australia's RMIT University have developed a wearable wound monitoring device with integrated sensors that could reduce infection risks by minimising the need for frequent physical contact.
1 min
BioSpectrum Asia Sep 2025
BioSpectrum Asia
Revvity unveils innovative reagent technology to accelerate therapeutics development
US-based Revvity, Inc. has announced the launch of pHSense reagents, a powerful technology designed to advance internalisation studies in drug discovery.
1 min
BioSpectrum Asia Sep 2025

BioSpectrum Asia
Sanofi acquires next-gen vaccine biotech Vicebio for $1.6 B
Vicebio, a biopharmaceutical company with operations in Australia, UK and Belgium, has entered an exclusive, definitive agreement to be acquired by Sanofi.
1 min
BioSpectrum Asia Sep 2025
BioSpectrum Asia
HOSMAC signs MoU with Gulf Medical University to strengthen healthcare education
HOSMAC, Asia's leading hospital planning, design, and management consultancy, has signed a Memorandum of Understanding (MoU) with Gulf Medical University (GMU), Ajman, UAE, to serve as an industry partner.
1 min
BioSpectrum Asia Sep 2025
BioSpectrum Asia
Jessica Cowden takes charge as Deputy Director General of CARE unit at IVI
Dr Jessica Cowden has been appointed Deputy Director General of the Clinical, Assessment, Regulatory, Evaluation (CARE) unit at South Korea-headquartered International Vaccine Institute (IVI). She will continue to be based at IVI's Europe Regional Office in Stockholm, Sweden.
1 min
BioSpectrum Asia Sep 2025
Listen
Translate
Change font size